{"doi":"10.1200/po.22.00715","title":"Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer","abstract":"<jats:sec><jats:title>PURPOSE</jats:title><jats:p>This review summarizes the published evidence on the clinical impact of using next-generation sequencing (NGS) tests to guide management of patients with cancer in the United States.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>We performed a comprehensive literature review to identify recent English language publications that presented progression-free survival (PFS) and overall survival (OS) of patients with advanced cancer receiving NGS testing.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>Among 6,475 publications identified, 31 evaluated PFS and OS among subgroups of patients who received NGS-informed cancer management. PFS and OS were significantly longer among patients who were matched to targeted treatment in 11 and 16 publications across tumor types, respectively.</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>Our review indicates that NGS-informed treatment can have an impact on survival across tumor types.</jats:p></jats:sec>","journal":"JCO Precision Oncology","year":2023,"id":640760,"datarank":0.635115975689589,"base_score":4.23410650459726,"endowment":4.23410650459726,"self_citation_contribution":0.635115975689589,"citation_network_contribution":0.0,"self_endowment_contribution":0.635115975689589,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":68,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":848542,"name":"Desi Peneva","orcid":"0000-0001-8637-2558","position":1,"is_corresponding":false},{"id":1665478,"name":"Gebra Cuyun Carter","orcid":"0000-0002-6549-0069","position":2,"is_corresponding":false},{"id":401863,"name":"Melanie R. Palomares","orcid":"0000-0003-4356-1724","position":3,"is_corresponding":false},{"id":1665479,"name":"Snehal Thakkar","orcid":null,"position":4,"is_corresponding":false},{"id":258657,"name":"David W. Hall","orcid":"0000-0001-7708-6656","position":5,"is_corresponding":false},{"id":1665480,"name":"Hannah Dalglish","orcid":"0000-0003-3153-3443","position":6,"is_corresponding":false},{"id":1665481,"name":"Cynthia Campos","orcid":"0000-0003-2277-0068","position":7,"is_corresponding":false},{"id":1665482,"name":"Irina Yermilov","orcid":null,"position":8,"is_corresponding":false},{"id":1665477,"name":"Sarah N. Gibbs","orcid":"0000-0002-1215-642X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer","abstract":"<jats:sec><jats:title>PURPOSE</jats:title><jats:p>This review summarizes the published evidence on the clinical impact of using next-generation sequencing (NGS) tests to guide management of patients with cancer in the United States.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>We performed a comprehensive literature review to identify recent English language publications that presented progression-free survival (PFS) and overall survival (OS) of patients with advanced cancer receiving NGS testing.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>Among 6,475 publications identified, 31 evaluated PFS and OS among subgroups of patients who received NGS-informed cancer management. PFS and OS were significantly longer among patients who were matched to targeted treatment in 11 and 16 publications across tumor types, respectively.</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>Our review indicates that NGS-informed treatment can have an impact on survival across tumor types.</jats:p></jats:sec>","is_dataset_classified":null,"base_score":4.23410650459726,"endowment":4.23410650459726,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"37285561","pmcid":"PMC10309568","openalex_id":"https://openalex.org/W4379618497","authors":[],"funders":[],"total_grants":0,"fwci":7.1444,"citation_percentile":0.98247202,"influential_citations":0,"citation_trend":[{"year":2023,"count":1},{"year":2024,"count":18},{"year":2025,"count":39},{"year":2026,"count":10}],"oa_status":"hybrid","license":"cc-by-nc-nd","oa_locations":[{"url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.22.00715?role=tab","host_type":"journal"},{"url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.22.00715?role=tab","host_type":"publisher"},{"url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO.22.00715","host_type":"publisher"},{"url":"https://doi.org/10.1200/po.22.00715","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/37285561","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10309568","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10309568/pdf/po-7-e2200715.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC10309568","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC10309568?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Cancer Genomics and Diagnostics","Lung Cancer Treatments and Mutations","Genetic factors in colorectal cancer","Humans","United States","Neoplasms","Progression-Free Survival","High-Throughput Nucleotide Sequencing"],"mesh_terms":["Progression-Free Survival","Humans","Neoplasms","United States","High-Throughput Nucleotide Sequencing"],"keywords":["Medicine","Cancer","Oncology","Internal medicine","Overall survival","Intensive care medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Quality Education"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-07T13:43:27.575746Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}